Sartorius Stedim Biotech S.A. (OTCMKTS:SDMHF – Get Free Report) saw a large increase in short interest during the month of May. As of May 15th, there was short interest totalling 35,300 shares, an increase of 23.4% from the April 30th total of 28,600 shares. Based on an average daily trading volume, of 1,100 shares, the days-to-cover ratio is presently 32.1 days.
Wall Street Analysts Forecast Growth
Separately, Royal Bank of Canada cut shares of Sartorius Stedim Biotech from an “outperform” rating to a “sector perform” rating in a research note on Wednesday, May 21st.
Read Our Latest Stock Analysis on SDMHF
Sartorius Stedim Biotech Stock Performance
About Sartorius Stedim Biotech
Sartorius Stedim Biotech SA engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products.
Read More
- Five stocks we like better than Sartorius Stedim Biotech
- How to Invest in Small Cap StocksÂ
- Archer’s Midnight Air Taxi Soars, But Stock Doesn’t Budge
- Canadian Penny Stocks: Can They Make You Rich?
- 3 Industrials Stocks Standing Out for Growth and Analyst Optimism
- Find and Profitably Trade Stocks at 52-Week Lows
- 3 Tech Stocks Insiders Are Buying: Speculative Plays for June
Receive News & Ratings for Sartorius Stedim Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sartorius Stedim Biotech and related companies with MarketBeat.com's FREE daily email newsletter.